跳至主要内容
临床试验/NCT06427044
NCT06427044尚未招募不适用

Effect of Bupivacaine Liposome Anterior Serratus Deep Block on Chronic Pain After Breast Cancer Surgery: a Randomized Controlled Study

Lu Hua1 个研究点 分布在 1 个国家目标入组 143 人开始时间: 2024年5月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
143
试验地点
1
主要终点
Incidence of chronic pain 3 months after surgery

研究概览

简要总结

This study aims to investigate the effect and influence of liposome bupivacaine anterior serrat plane block on postoperative chronic pain in breast cancer patients, evaluate the therapeutic effect of liposome bupivacaine in postoperative chronic pain, and provide a new method for patients with postoperative chronic pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Adult patients (aged ≥18 years) who are scheduled to undergo unilateral modified radical breast cancer surgery

排除标准

  • Patients with coagulation dysfunction
  • There are infected patients at the puncture site
  • For patients allergic to any trial drug
  • Patients who take painkillers within 48 hours before surgery
  • Severe cardiopulmonary insufficiency, such as EF< 40%, FEVC < 50% expected; Uncontrolled hypertension;
  • Refuse to perform nerve block puncture
  • Mental disorders, epilepsy history;
  • Unable to give informed consent or are participating in other clinical trials.

研究组 & 干预措施

Anterior serratus block group

Experimental

Bupivacaine lipid 20mL (20mL 266mg bupivacaine liposomes) was ultrasound-guided for a single anterior serranus plane block

干预措施: Anterior serratus block group (Drug)

结局指标

主要结局

Incidence of chronic pain 3 months after surgery

时间窗: Three months after surgery

Pain levels were measured three months after surgery

次要结局

未报告次要终点

研究者

发起方
Lu Hua
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Lu Hua

Assistant Professor

Tongji Hospital

研究点 (1)

Loading locations...

相似试验